Uji klinis Katarak di Texas
7 studi untuk Katarak mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
- Berkeley Eye Center, Houston
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06922084A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects
- Berkeley Eye Center - Sugar Land, Sugar Land
Menerima pesertaFase 4
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT07693205Clareon TruPlus Study
- Berkeley Eye Center, Sugar Land
Menerima peserta
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT07502456IC-8 Apthera IOL New Enrollment Post Approval Study
- Berkeley Eye Center, Sugar Land
Menerima pesertaStudi observasional
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 12 Jan 2026 · NCT06060041Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Menerima pesertaFase 3
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT07218783Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Menerima pesertaFase 3
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT07218796Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Methodist Eye Associates | Houston Methodist, Houston
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2024 · NCT05438732Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.